Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acumapimod in acute COPD exacerbation
NCT01332097Phase 2Completed
- Sponsor
- Mereo BioPharma
- Start
- Mar 2011
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of acumapimod in chronic obstructive pulmonary disease (COPD), sponsored by Mereo BioPharma. Started Mar 2011; status: completed.
02
Drugs
acumapimod
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01332097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01332097.